Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy.
Chen L, Shen C, Redmond KJ, Page BR, Kummerlowe M, Mcnutt T, Bettegowda C, Rigamonti D, Lim M, Kleinberg L. Chen L, et al. Among authors: kummerlowe m. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):939-947. doi: 10.1016/j.ijrobp.2017.02.031. Epub 2017 Feb 21. Int J Radiat Oncol Biol Phys. 2017. PMID: 28602418
Imaging and Clinical Profile Following Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases: Preliminary Results.
Shen C, Lin DD, Redmond KJ, Link K, Kummerlowe M, Douglass J, Lipson EJ, Sharfman W, Bettegowda C, Lim M, Kleinberg LR. Shen C, et al. Among authors: kummerlowe m. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E134. doi: 10.1016/j.ijrobp.2016.06.927. Int J Radiat Oncol Biol Phys. 2016. PMID: 27673866 No abstract available.
Combined modality therapy improves overall survival for angiosarcoma.
Shen CJ, Parzuchowski AS, Kummerlowe MN, Morris CD, Meyer CF, Habibi M, Frassica DA, Levin AS, Thornton KA, Terezakis SA. Shen CJ, et al. Among authors: kummerlowe mn. Acta Oncol. 2017 Sep;56(9):1235-1238. doi: 10.1080/0284186X.2017.1306104. Epub 2017 Mar 30. Acta Oncol. 2017. PMID: 28358642 No abstract available.
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
Kapoor R, Deek MP, McIntyre R, Raman N, Kummerlowe M, Chen I, Gaver M, Wang H, Denmeade S, Lotan T, Paller C, Markowski M, Carducci M, Eisenberger M, Beer TM, Song DY, DeWeese TL, Hearn JW, Greco S, DeVille C, Desai NB, Heath EI, Liauw S, Spratt DE, Hung AY, Antonarakis ES, Tran PT. Kapoor R, et al. Among authors: kummerlowe m. BMC Cancer. 2019 Jun 13;19(1):572. doi: 10.1186/s12885-019-5805-z. BMC Cancer. 2019. PMID: 31196032 Free PMC article.
14 results